Clinical Trial Update: SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial of the SYNergy Stent System using intravascular ultrasound guidance with dual antiplatelet therapy was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease

Snippet

Sponsor: HonorHealth Research Institute | Conditions: Coronary Artery Disease, Atherosclerosis | Phase 2 | Status: TERMINATED | Results posted: 2024-12-27